AzTrials
AzTrials

Arterial CatheterizationNCT07062861

Proximal and Distal Radial Artery Cannulation in Children

An observational study of Arterial Catheterization and Radial Atrery Cannulation, run by Marmara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intraarterial cannulation is important for continuous blood pressure monitoring and blood gas analysis throughout the surgical procedure and in intensive care patients. Ultrasonography (USG) has gained popularity in vascular cannulations and facilitates intraarterial interventions. Read more about this study

Who is it for?
Ages 4 to 14 years
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
28 Aug 2025to 21 Apr 2026
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Pediatric patients aged 4-14 years undergoing elective surgery under general anesthesia.

Who may be able to join

  • PEDIATRIC patients undergoing elective surgery
  • ASA I-III physical status

Who cannot join

  • Refusal to participate in the study
  • Those with peripheral vascular disease
  • Vasopressor drug users
  • Infection or anatomical defects at the site of the procedure
  • Patients with coagulation disorders

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University Pendik Training and Research Hospital

    Istanbul, Istanbul, 34912

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Proximal and Distal Cannulation of the Radial Artery by Ultrasonography in Pediatric Patients Undergoing Elective Surgery

Intraarterial cannulation is important for continuous blood pressure monitoring and blood gas analysis throughout the surgical procedure and in intensive care patients. Ultrasonography (USG) has gained popularity in vascular cannulations and facilitates intraarterial interventions. Radial artery is one of the most preferred arteries. Our aim in this study is to compare proximal and distal radial artery cannulations by USG in pediatric patients in terms of procedural success, procedure time and complications.

Read the detailed description

After the patients are admitted to the operating room, routine monitoring (electrocardiography, noninvasive blood pressure and peripheral oxygen saturation) will be performed. After appropriate vascular access is provided to the patients, the induction phase of general anesthesia will begin. Anesthesia induction will be left to the choice of the primary anesthesiologist and no protocol will be followed. In case of >25% drop in blood pressure, 0.1 mcg/kg noradrenaline will be administered intravenously. After the appropriate position is given to the arm of the patient to be treated, radial artery cannulation will be performed with USG obeying asepsis rules. Patients will be divided into 2 groups. The first group will be the patients who will be cannulated at the level of the distal radius (styloid process). For the second group, proximal radial artery cannulation will be performed proximally from the styloid process by measuring 1 cm in patients under 20 kg, 2 cm between 20-30 kg, 3 cm between 30-40 kg, 4 cm between 40-50 kg, and 5 cm in patients over 50 kg. Demographic and clinical characteristics of the patients will be recorded. Catheterization success rates, procedure duration, number of interventions, vessel diameter, hematoma at the site of intervention on the 1st postoperative day, circulatory disturbance will be examined.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07062861
Study groupRoleWhat they receive
Group PRadial arterial cannulation from the proximal part of the artery.
Group DRadial arterial cannulation from the distal part of the artery.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate

    Radial artery catheterization success rates will be compared between the groups.

    Measured: From the preinduction period in the operating theater to the postoperative day one.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2025
  2. Study start28 Aug 2025
  3. Primary completion20 Apr 2026
  4. Study completion21 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07062861
Sponsor's protocol ID
09.2025.25-0131
Status last verified
Apr 2026
First submitted
3 Jul 2025
Last updated
29 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Will be decided at the end of the study.

Questions about this trial

What is this clinical trial studying?

An observational study of Arterial Catheterization and Radial Atrery Cannulation, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate (time frame: From the preinduction period in the operating theater to the postoperative day one.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in